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INTRODUCTION
Fever is a common manifestation in patients with systemic
lupus erythematosus. Causes for fever in patients with
lupus include disease activity, infection, malignancy and
drug reactions. Neutropenia is defined as an ANC less
than 1.5 x 109 /L. It occurs in about 50% of patients with
lupus and can occur even when the patient is not in a
flare. The neutropenia of lupus is usually due to peripheral
destruction and not due to bone marrow suppression.

testing was done to look for the source of the infection,
but all returned negative. Since fevers and neutropenia
persisted without a source, a bone marrow biopsy was
done revealing myelofibrosis with active granulopoiesis.
The patient was negative for both JAK V617K mutation
and BCL/ABL transcription, consistent with the diagnosis
of autoimmune myelofibrosis. She was started on
prednisone and within 48 hours was afebrile, feeling well
and able to maintain normal ANC and WBC count.

CASE PRESENTATION
20 year old female with lupus nephritis controlled with
mycophenolate mofeti, was admitted complaining of
fever and intermittent chest pain. On admission, she had
a temperature of 101.1 and negative cardiac studies.
Blood work showed she was neutropenic with a WBC
count of 1.6 and ANC of 0.1 thou/cmm including a few
promyelocytes, myelocytes and metamyelocytes. Her
renal function was normal. Further work up reveled
low complement levels, elevated sedimentation
rate, positive ANA, and elevated dsDNA antibodies.
According to previous records, the patient had never
been neutropenic. Physical exam of the patient was
relatively unremarkable. Her chest pain was reproducible
and localized to the right side of her chest and throat
exam revealed one oral ulcer. No heptosplenomegaly,
joint inflammation, or skin rash were seen. The patient
was started on antibiotics, mycophenolate mofeti was
stopped, and she was given filgrastim (Neupogen) which
only transiently improved her ANC to normal limits.
Despite these measures her fever persisted, further

DISCUSSION
Patients with SLE often have hematologic abnormalities
and fevers as a component of their disease. Autoimmune
myelofibrosis is a rare cause of these abnormalities in
patents with lupus, but should be considered when
peripheral blood smears are abnormal. Bone marrow
biopsy should be considered when myeloid/red blood
cell precursors and tear drop cells are seen. Autoimmune
myelofibrosis differs from primary myelofibrosis in the
following ways:
• splenomegaly is rarely seen
• there are only mild numbers of (daptocytes) or tear drop
red cells and immature myeloid cells in the peripheral
blood
• patients have a positive direct antiglobin test and ANA,
but negative JAK mutation and BCL/ABL transcription
• autoimmune myelofibrosis responds well to steroids
and IgG
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UPDATE
The patient is clinically doing well, symptoms
have resolved. She has been off of filgrastim
(Neupogen) for over a month with stable
neutrophil counts. For treatment, she is still
undergoing a slow steroid taper, but her
autoimmune markers have now normalized
and she shows no clinical signs of disease
activity. The patient was also seen at another
institution where she had a repeat bone
marrow biopsy which showed a significant
decrease in myelofibrosis. The idea of acute
megakaryoblastic leukemia with myelofibrosis
was also entertained, but seems unlikely with
the absence of dysmorphic cells in the bone
marrow. This would be a rare and devastating
cause for the patient’s symptoms, as few
patients survive beyond three years with
this diagnosis. Another idea currently being
considered is whether the myelofibrosis
is related to the mycophenolate mofeti.
There are very rare reports of myelofibrosis
developing in transplant patients who
had been treated with cyclosporine A and
mycophenolate mofeti. Patient currently
remains off of mycophenolate mofeti.

This case exhibited an atypical cause for some common
manifestations of lupus.
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